Hubbard Cristin 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed May 6, 2025
Insider Transaction Report
Form 4
Hubbard Cristin
EVP, Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-05-02$64.92/sh−273$17,723→ 32,700 total - Award
Common Stock
2025-04-30$54.14/sh+273$14,779→ 32,973 total
Footnotes (2)
- [F1]Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan.
- [F2]Trade made pursuant to a 10b5-1 plan executed on September 13, 2024.